Kissei Pharmaceutical Co., Ltd. (OTCMKTS:KSPHF) Sees Significant Growth in Short Interest

Kissei Pharmaceutical Co., Ltd. (OTCMKTS:KSPHF) was the target of a large growth in short interest in the month of January. As of January 31st, there was short interest totalling 122,400 shares, a growth of 5.6% from the January 15th total of 115,900 shares. Based on an average daily trading volume, of 300 shares, the days-to-cover ratio is presently 408.0 days.

Kissei Pharmaceutical Stock Performance

Shares of Kissei Pharmaceutical stock opened at $23.26 on Wednesday. The company has a 50 day moving average of $24.30 and a 200 day moving average of $23.71. Kissei Pharmaceutical has a 52-week low of $23.26 and a 52-week high of $24.05.

About Kissei Pharmaceutical

Kissei Pharmaceutical Co, Ltd. researches, develops, manufactures, and sells pharmaceutical products primarily in Japan. The company offers Kalogra tablets, for the treatment of ulcerative colitis; Tabuneos capsules for the treatment of microscopic polyangiitis and granulomatous polyangiitis; Minirin Melt OD tablets; Malizeb tablets; Tavaris tablets for the treatment of chronic idiopathic thrombocytopenic purpura; Beova tablets for the treatment of overactive bladder treatment; and Darbepoetin Alfa BS injection JCR for the treatment of renal anemia.